The burden of Clostridioides difficile on COVID‐19 hospitalizations in the USA
- 29 January 2023
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 38 (4), 590-597
- https://doi.org/10.1111/jgh.16128
Abstract
Background and AimClostridioides difficile infection (CDI) is the leading cause of hospital acquired-infectious diarrhea in the USA. In this study, we assess the prevalence and impact of CDI in COVID-19 hospitalizations in the USA. MethodsWe used the 2020 National Inpatient Sample database to identify adult patients with COVID-19. The patients were stratified into two groups based on the presence of CDI. The impact of CDI on outcomes such as in-hospital mortality, ICU admission, shock, acute kidney injury (AKI), and sepsis rates. Multivariate regression analysis was performed to assess the effects of CDI on outcomes. ResultsThe study population comprised 1581 585 patients with COVID-19. Among these, 0.65% of people had a CDI. There was a higher incidence of mortality in patients with COVID-19 and CDI compared with patients without COVID-19 (23.25% vs 13.33%, P < 0.001). The patients with COVID-19 and CDI had a higher incidence of sepsis (7.69% vs 5%, P < 0.001), shock (23.59% vs 8.59%, P < 0.001), ICU admission (25.54% vs 12.28%, P < 0.001), and AKI (47.71% vs 28.52%, P < 0.001). On multivariate analysis, patients with CDI had a statistically significant higher risk of mortality than those without (aOR = 1.47, P < 0.001). We also noted a statistically significant higher risk of sepsis (aOR = 1.47, P < 0.001), shock (aOR = 2.7, P < 0.001), AKI (aOR = 1.55, P < 0.001), and ICU admission (aOR = 2.16, P < 0.001) in the study population. ConclusionsOur study revealed the prevalence of CDI in COVID-19 patients was 0.65%. Although the prevalence was low, its presence is associated with worse outcomes and higher resource utilization.Keywords
This publication has 46 references indexed in Scilit:
- Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitalsBMC Infectious Diseases, 2017
- Risk factors for Clostridium difficile infections – an overview of the evidence base and challenges in data synthesisJournal of Global Health, 2017
- Impact of Clostridium difficile infection in patients hospitalized with acute pancreatitis- a population based cohort studyPancreatology, 2017
- Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infectionThe Korean Journal of Internal Medicine, 2015
- Burden of Clostridium difficile Infection in the United StatesThe New England Journal of Medicine, 2015
- Outcomes of Clostridium difficile Infection in Hospitalized Leukemia Patients: A Nationwide AnalysisInfection Control & Hospital Epidemiology, 2015
- Clostridium difficile infection in diabetesDiabetes Research and Clinical Practice, 2014
- Clostridium difficile infection in hospitalized liver transplant patients: A nationwide analysisLiver Transplantation, 2012
- Mortality and Clostridium difficile infection: a reviewPublished by Springer Science and Business Media LLC ,2012
- The Emerging Infectious Challenge of Clostridium difficile-Associated Disease in Massachusetts Hospitals: Clinical and Economic ConsequencesInfection Control & Hospital Epidemiology, 2007